AVTXA Stock Overview
A chemical technology company, develops and commercializes renewable chemistry solutions in the Netherlands. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Avantium N.V. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €1.82 |
52 Week High | €1.82 |
52 Week Low | €1.82 |
Beta | 0.95 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -63.09% |
Recent News & Updates
Recent updates
Shareholder Returns
AVTXA | GB Professional Services | GB Market | |
---|---|---|---|
7D | 0% | -4.4% | -0.3% |
1Y | n/a | 18.2% | 6.1% |
Return vs Industry: Insufficient data to determine how AVTXA performed against the UK Professional Services industry.
Return vs Market: Insufficient data to determine how AVTXA performed against the UK Market.
Price Volatility
AVTXA volatility | |
---|---|
AVTXA Average Weekly Movement | n/a |
Professional Services Industry Average Movement | 4.5% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 10.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: AVTXA's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine AVTXA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 288 | Tom van Aken | www.avantium.com |
Avantium N.V., a chemical technology company, develops and commercializes renewable chemistry solutions in the Netherlands. The company operates through three segments: Avantium R&D Solutions, Avantium Renewable Chemistries, and Avantium Renewable Polymers. It offers furandicarboxylic acid, a building block for polyethylene furanoate (PEF); and PEF, a plant-based recyclable plastic for use as packaging material.
Avantium N.V. Fundamentals Summary
AVTXA fundamental statistics | |
---|---|
Market cap | €173.69m |
Earnings (TTM) | -€29.07m |
Revenue (TTM) | €21.40m |
8.1x
P/S Ratio-6.0x
P/E RatioIs AVTXA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AVTXA income statement (TTM) | |
---|---|
Revenue | €21.40m |
Cost of Revenue | €48.99m |
Gross Profit | -€27.59m |
Other Expenses | €1.48m |
Earnings | -€29.07m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 19, 2025
Earnings per share (EPS) | -0.36 |
Gross Margin | -128.95% |
Net Profit Margin | -135.85% |
Debt/Equity Ratio | 101.2% |
How did AVTXA perform over the long term?
See historical performance and comparison